<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00966199</url>
  </required_header>
  <id_info>
    <org_study_id>MBRACE</org_study_id>
    <secondary_id>2008B113</secondary_id>
    <nct_id>NCT00966199</nct_id>
  </id_info>
  <brief_title>The Effects of Blood Pressure Reduction on Cerebral Perfusion and Cognition in the Elderly Population</brief_title>
  <acronym>MBRACE</acronym>
  <official_title>Medication Induced Blood Pressure Reduction; Assessment of Cerebral Perfusion and Cognition in Hypertensive Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dutch Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if a reduction in systolic blood pressure induced
      by anti-hypertensive medication results in changes in cerebral perfusion and cognition in
      hypertensive elderly. Hypertensive elderly will be treated using open-label anti-hypertensive
      medication for 8-12 weeks. Changes in cerebral perfusion and cognition will be assessed
      before and after treatment.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral blood flow</measure>
    <time_frame>T1, 8-12 weeks of treatment, T2</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive functioning assessed by neuropsychological testing</measure>
    <time_frame>T1, 8-12 weeks of treatment, T2-3</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Hypertensive elderly</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>community dwelling hypertensive elderly from general practices</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>anti-hypertensive medication</intervention_name>
    <description>8-12 weeks of anti-hypertensive treatment with 2 weekly titration using registered hypertensive medication</description>
    <arm_group_label>Hypertensive elderly</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;= 70 years

          -  Systolic office blood pressure &gt;= 160 mmHg

          -  Systolic home blood pressure &gt;= 155 mmHg

        Exclusion Criteria:

          -  Diabetes Mellitus

          -  Atrial fibrillation

          -  Dementia

          -  Renal failure requiring dialysis

          -  Life expectancy of less than 1 year

          -  Disabling stroke

          -  Contraindication for MRI or anti-hypertensive medication

          -  Systolic blood pressure &gt; 220 mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jurgen A Claassen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jaap C Sijbesma, MD</last_name>
    <phone>0243616772</phone>
    <phone_ext>+31</phone_ext>
    <email>J.Sijbesma@ger.umcn.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Radboud University</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <zip>6500HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jaap C Sijbesma, MD</last_name>
      <phone>0243616772</phone>
      <phone_ext>+31</phone_ext>
      <email>J.Sijbesma@ger.umcn.nl</email>
    </contact>
    <investigator>
      <last_name>Jaap C Sijbesma, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jurgen A Claassen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2009</study_first_submitted>
  <study_first_submitted_qc>August 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2009</study_first_posted>
  <last_update_submitted>August 25, 2009</last_update_submitted>
  <last_update_submitted_qc>August 25, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 26, 2009</last_update_posted>
  <responsible_party>
    <name_title>J.A.H.R. Claassen, MD, PhD</name_title>
    <organization>Radboud University Nijmegen Medical Centre</organization>
  </responsible_party>
  <keyword>blood pressure</keyword>
  <keyword>aging</keyword>
  <keyword>cerebrovascular circulation</keyword>
  <keyword>hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antihypertensive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

